Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials

Show other versions (2)

Bibliographic Details
Main Authors:	Rothwell, P, Price, J, Fowkes, F, Zanchetti, A, Roncaglioni, M, Tognoni, G, Lee, R, Belch, J, Wilson, M, Mehta, Z, Meade, T
Format:	Journal article
Published:	2012

Similar Items

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials
by: Rothwell, P, et al.
Published: (2012)

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.
by: Rothwell, P, et al.
Published: (2012)

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.
by: Rothwell, P, et al.
Published: (2011)

Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomised controlled trials
by: Rothwell, P, et al.
Published: (2012)

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.
by: Rothwell, P, et al.
Published: (2012)

Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomised controlled trials
by: Rothwell, P, et al.
Published: (2012)

Effect of Daily Aspirin on Long-Term Risk of Death Due to Cancer: Analysis of Individual Patient Data From Randomized Trials
by: Rothwell, P, et al.
Published: (2011)

Efficacy of aspirin in people with diabetes: an individual participant data meta-analysis of 26 randomised trials
by: Wong, C, et al.
Published: (2014)

Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
by: Rothwell, P, et al.
Published: (2018)

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
by: Baigent, C, et al.
Published: (2009)

Effects on colon cancer risk in randomised trials of aspirin
by: Rothwell, P
Published: (2011)

Randomised trial of prophylactic daily aspirin in British male doctors.
by: Peto, R, et al.
Published: (1988)

Randomised trial of prophylactic daily aspirin in British male doctors.
by: Weber, E
Published: (1988)

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial
by: Gaziano, J, et al.
Published: (2018)

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.
by: Rothwell, P, et al.
Published: (2010)

Individual-patient meta-analysis: Daily aspirin reduces risk for incident cancer with distant metastasis
by: Rothwell, P
Published: (2012)

Aspirin in prevention of sporadic colorectal cancer: current clinical evidence and overall balance of risks and benefits.
by: Rothwell, P
Published: (2013)

Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
by: Rothwell, PM, et al.
Published: (2016)

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
by: Flossmann, E, et al.
Published: (2007)

ADAMTS13 is a Risk Factor for MI, Stroke and Vascular Death in the Oxford Vascular Study
by: Eglinton, J, et al.
Published: (2008)

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.
by: Collins, R, et al.
Published: (1996)

Aspirin in the prevention of cancer Reply
by: Rothwell, P
Published: (2011)

Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)
by: Hamzah Khan, et al.
Published: (2021-12-01)

Critical Overview on the Benefits and Harms of Aspirin
by: Chun Shing Kwok, et al.
Published: (2010-05-01)

Aspirin in the primary prevention of vascular disease Reply
by: Baigent, C, et al.
Published: (2009)

Aspirin in the primary prevention of vascular disease Reply
by: Baigent, C, et al.
Published: (2009)

Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials
by: Samuel Seidu, et al.
Published: (2019-06-01)

Aspirin for primary prevention of vascular disease in people with diabetes.
by: Haynes, R, et al.
Published: (2009)

Cardiac, renal and vascular complications in the diabetic patient
by: Alberto Zanchetti
Published: (2000-06-01)

Cardiac, renal and vascular complications in the diabetic patient
by: Alberto Zanchetti
Published: (2000-06-01)

Aspirin, salicylates and cancer
by: Morgan, G, et al.
Published: (2011)

5.1 EPOXYEICOSATRIENOIC ACIDS IN THE REGULATION OF VASCULAR TONE
by: L. Yang, et al.
Published: (2014-11-01)

Effects of regular aspirin on long-term cancer incidence and metastasis: A systematic comparison of evidence from observational studies versus randomised trials
by: Algra, A, et al.
Published: (2012)

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.
by: Algra, A, et al.
Published: (2012)

Age-Specific Risk and Severity of Bleeding on Aspirin-based Secondary Prevention: A Population-Based Study
by: Geraghty, O, et al.
Published: (2012)

Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
by: Kunicki, T, et al.
Published: (2009)

Alternate-day, low-dose aspirin and cancer risk.
by: Rothwell, P
Published: (2013)

CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES
by: P. J. Dovgalevsky, et al.
Published: (2016-01-01)

Benefit of aspirin plus angiotensin-converting enzyme inhibitor.
by: Baigent, C, et al.
Published: (2001)

Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
by: Hamzah Khan, et al.
Published: (2022-08-01)